Abonnement for 2 €

Sikre fra 2 euro

Institutional-grade intelligence for professional investors

LIVE

•Real-time feeds•Global markets•24/7 coverage

Cue Biopharma Aktie News & Pressemeldungen

Cue Biopharma Eulerpool Nyheter

Cue Biopharma Aksje Nyheter

Cue Biopharma blir fulgt av mange journalister og investorer over hele verden. De nyeste Cue Biopharma nyhetene presenterer vi her.

·
Yahoo
Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company’s Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease
·
Yahoo
Earnings Preview: Opus Genetics, Inc. (IRD) Q1 Earnings Expected to Decline
·
Yahoo
Cue Biopharma to Host Business Update Call and Webcast
·
Yahoo
Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
·
Yahoo
Cue Biopharma Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
·
Yahoo
Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength?
·
Yahoo
Cue Biopharma Third Quarter 2024 Earnings: Beats Expectations
·
Yahoo
Cue Biopharma Announces Strategic Organizational Transition
·
Yahoo
Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
·
Yahoo
Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting

1

2

1

2

Cue Biopharma Aksje Pressemeldinger

Cue Biopharma publiserer regelmessig meldinger som er relevante for investorer på selskapets nettside.

Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Sikre deg fra 2 euro

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan